Surging global incidence of human papillomavirus (HPV)-associated malignancies, expanding clinical adoption of immune checkpoint inhibitors for recurrent and metastatic disease, and continuous oncology innovations in intensity-modulated radiation therapy (IMRT) are driving rapid growth across the global Anal Cancer Market. Anal cancer therapeutics and diagnostics—comprising PD-1/PD-L1...
